Related Experiment Video
Updated: Jul 18, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Drug discovery and development for neglected parasitic diseases
Adam R Renslo1, James H McKerrow
1Department of Pharmaceutical Chemistry and the Small Molecule Discovery Center, University of California-San Francisco, San Francisco, CA 94158, USA.
Abstract:
Diseases caused by tropical parasites affect hundreds of millions of people worldwide but have been largely neglected for drug development because they affect poor people in poor regions of the world. Most of the current drugs used to treat these diseases are decades old and have many limitations, including the emergence of drug resistance. This review will summarize efforts to reinvigorate the drug development pipeline for these diseases, which is driven in large part by support from major philanthropies. The organisms responsible for these diseases have a fascinating biology, and many potential biochemical targets are now apparent. These neglected diseases present unique challenges to drug development that are being addressed by new consortia of scientists from academia and industry.
More Related Videos
10:03Development of Leishmania Species Strains with Constitutive Expression of eGFP
Published on: April 21, 2023
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
Related Concept Videos
Anthelminthic Agents
Antiprotozoal Agents
Drug Discovery: Overview
American Trypanosomiasis
Malaria
Leishmaniasis